Grace Lieblein, who serves on the board of Honeywell International Inc, executed an open-market sale of 5,857 shares of Honeywell common stock on February 23, 2026. The shares were sold at $243.73 each, producing proceeds of roughly $1.4 million. That sale price sat just under the company stock's 52-week peak of $246.
Also on February 23, Lieblein exercised stock options to acquire a total of 7,777 Honeywell shares. Those option exercises carried prices ranging from $117.58 to $163.47, representing a combined value of $1,058,696 based on the exercise prices disclosed.
The transactions took place against the backdrop of valuation commentary on Honeywell. The industrial conglomerate is valued at approximately $155 billion and trades at a price-to-earnings ratio of 35.45. Analysis from InvestingPro cited in company materials indicates the stock is trading above its Fair Value and lists Honeywell among companies flagged as Most Overvalued.
Beyond insider activity, Honeywell announced a revised purchase agreement to acquire Johnson Matthey's Catalyst Technologies division for
The revised purchase price for the Catalyst Technologies unit is
Honeywell said the deadline to complete the acquisition has been extended to July 21, 2026, and may be further prolonged to August 21, 2026, pending regulatory approvals. Johnson Matthey has disclosed plans to return to shareholders from the sale proceeds, including an
In its reporting for the fourth quarter of 2025, Honeywell posted earnings per share of $2.59 and revenue of $10.1 billion, both of which exceeded analysts' expectations. The company also declared a quarterly cash dividend of $1.19 per share, with the payment scheduled for March 13, 2026.
Honeywell disclosed additional impairment charges within its Industrial Automation segment totaling $436 million, alongside a $35 million impairment charge related to assets held for sale. These charges were listed in the company's disclosures and reflect adjustments in that business area.
Taken together, the director's share sale and option exercises occurred amid active corporate developments at Honeywell, including strategic transactions, updated financial results, and segment-level impairment recognition.